.jpg)
Patient Centricity
Patient Centricity is a ZS podcast focused on unpacking the provocative insights featured in the book, “Reinventing Patient Centricity: Bringing Patient-led Business Models to Life,” published in May 2022. Over the course of 12 chapters, coauthors Sharon Suchotliff, associate principal at ZS, and Hensley Evans, principal at ZS, explore opportunities for life sciences companies to move beyond the buzzwords and adopt truly patient-led business models.
In the podcast series, host Victoria Summers invites colleagues and patients to examine various dimensions of patient centricity. Topics include the impact of patient centricity, new models of patient engagement, Patient Focused Drug Development (PFDD) as well as how to transform the life sciences industry and, ultimately, the patient experience. Interviewees share their expertise, discuss case studies and give voice to patient stories.
Special bonus content features patients sharing their own stories – their journey, challenges they have faced and their hopes for the future.
Hosted by Victoria Summers, principal at ZS and East Coast lead for ZS’s patient health and equity accelerator.
Learn more about ZS’s work in Patient and Consumer Health.
Purchase your copy of the book.
ZS is a management consulting and technology firm focused on transforming global healthcare and beyond. We leverage our leading-edge analytics, plus the power of data, science and products to help our clients make more intelligent decisions, deliver innovative solutions and improve outcomes for all. Founded in 1983, ZS has more than 12,000 employees in 35 offices worldwide. To learn more, visit www.zs.com or follow us on Twitter and LinkedIn.
Patient Centricity
"Patients in their own words" -- Nathan's story
Nathan Peck is the CEO of Cure VCP Disease, a VCP disease patient, husband and father.
Nathan possesses a Bachelor of Industrial Engineering from the Georgia Institute of Technology as well as an MBA and Masters of Civil and Environmental Engineering from the Massachusetts Institute of Technology. As a patient, in January 2018, he formed Cure VCP Disease, Inc. along with a passionate group of IBMPFD patients, caregivers and researchers. Through Cure VCP Disease, Inc. he is committed to bringing together patients, caregivers, researchers, pharmaceutical companies, other non-profits and investors to identify treatments and ultimately a cure for this ultra-rare, genetic disease. Being a patient with the disease drives the organization’s urgency and purpose.
In Nathan’s own words, “our goal is to make Cure VCP disease extinct… I don't want this organization to become big and long lasting. I want it to die because we conquered the disease, and we helped others in the process.”
See below for more information on Cure VCP Disease:
Website: https://www.curevcp.org/
What is VCP disease: https://youtu.be/behsJnCjbrk
Help support Cure VCP Disease: https://givebutter.com/2023VCPScientificProgram
Email: info@curevcp.org
Produced by Samantha Keyes and Georgianna Moreland
